News

Vistin Pharma Announces Q1 2025 Results and Conference Call

Vistin Pharma Announces Q1 2025 Results and Conference Call

Vistin Pharma's Upcoming Quarter Results Conference Call

Vistin Pharma ASA (VISTN) is excited to announce the release of its first quarter results. This significant event is set for a future date in April 2025, when the company will share its performance insights with shareholders and interested parties. A conference call is scheduled to take place on the same day at 08:30 CET, allowing participants to engage in a discussion and ask questions afterward.

How to Join the Conference Call

The conference call will be accessible in English, ensuring clear communication for all participants. This allows a broad audience to stay informed and involved with Vistin Pharma's latest developments.

The call will be available through both web and audio platforms. Participants can easily tune in via the following access points:

Webcast: Join the Webcast Here

Telephone Conference Registration:

Register for the Call

Key Information About Vistin Pharma

For participants who are interested in learning more about the organization, further information will be made available during the call. Vistin Pharma is a leading Norwegian pharmaceutical company responsible for producing Metformin Hydrochloride (API), with a specialty in Direct Compressible lubricated granules. As the only dedicated European Metformin producer, Vistin Pharma holds a strategic advantage as a supplier to esteemed pharmaceutical companies.

Headquartered in Oslo, Norway, the company prides itself on its highly skilled team and a state-of-the-art manufacturing facility located in Kragerø. Their commitment to quality and excellence positions them as a key player in the pharmaceutical industry.

Contact Information

For additional questions or further details, interested individuals can reach out to:
Alexander Karlsen
CFO
Phone: +47 97053621
Email: alexander.karlsen@vistin.com

Frequently Asked Questions

What is the date and time for the Q1 2025 results conference call?

The conference call is scheduled for a future date in April 2025 at 08:30 CET.

How can I access the conference call?

You can join the conference call via web and audio through the links provided in the announcement.

What products does Vistin Pharma specialize in?

Vistin Pharma specializes in producing Metformin Hydrochloride and Direct Compressible lubricated granules.

Where is Vistin Pharma located?

Vistin Pharma is headquartered in Oslo, Norway, with a manufacturing facility in Kragerø.

Who should I contact for further information?

For more information, you can contact Alexander Karlsen, the CFO, at +47 97053621 or via email at alexander.karlsen@vistin.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Papa John's Faces Securities Class Action Over Missteps

Updated Category News Views 3

Papa John's Stock Takes a Nosedive Here's a hot potato for you—Papa John's International, Inc. (NASDAQ: PZZA) just got slapped with a securities class action. This ain't a pie you want a slice of, not after the dough they lost in a day's trading frenzy. On August 6, our friends at Papa John's sent their investors scrambling as their stock tumbled from $29.75 to a stark...

Continue Reading
Dreame's High-Tech Kitchen Innovations Unveiled at IFA 2026

Updated Category News Views 3

The Gadgets Turning Heads at IFA 2026 Cooking's gone high-tech, and it's about time. At the IFA 2026 in Berlin, Dreame Technology rolled out some primo small kitchen appliances that might just leave the old-school gear collecting dust. We're talking slick machines across six major categories: air fryers, coffee gizmos, mixers, blenders, toasters, and treat makers. Forget...

Continue Reading
Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
PrimeBOT Shines at IFA 2026 with Innovative Awards

Updated Category News Views 5

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 0

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 0

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading
Midea Unveils SMART MASTER at IFA 2026: AI in Action

Updated Category News Views 2

Introduction: Midea Takes the Stage at IFA 2026 Ah, the glitz of a tech expo. This time around, Midea's making waves at IFA 2026. Their SMART MASTER system could be another notch in their belt if they pull off this seamless AI integration they keep yapping about. It's all about creating a home ecosystem that feels like it's actually got a brain—or so they say. Let's dig...

Continue Reading
GoDaddy Faces Class Action: Investor Stakes High

Updated Category News Views 3

GoDaddy's Legal Turbulence: What's at Stake? Sometimes riding the stock wave can hit unexpected snags, and that's what's up with GoDaddy right now. They're stuck in the middle of a securities deception storm that's sending shivers down the spine of many an investor. The Class Action Lawsuit's Core Here's what you need to know: GoDaddy, with its ticker NYSE:GDDY, is...

Continue Reading
Iwa Robotics Unveils Autonomous Drone Wildfire Fleet

Updated Category News Views 2

A Sky Full of Drones: A New Era for Wildfire Management Iwa Robotics is flipping the script on how we handle urban wildfires by rolling out a trio of drones straight out of an action movie: HAWK, CANARY, and PELICAN. These aren't just your run-of-the-mill flying machines. They're the latest tech-packed companions for our brave firefighters on the ground, designed...

Continue Reading

Top 5 Most Recently Viewed Articles

Texas A&M’s Innovation Triangle: A New Frontier in Aerospace

Updated Category News Views 532

The Innovation Triangle Initiative by Texas A&M Texas A&M Innovation, in partnership with Plug and Play and the Greater Brazos Partnership, recently launched an exciting new program aimed at bolstering the aerospace and defense industries. This initiative, known as The Innovation Triangle, serves as a vital collaborative effort designed to enhance growth within these...

Continue Reading
Global Atomic Corporation Secures C$35 Million Offering Increase

Updated Category News Views 123

Global Atomic Corporation's Public Offering Upsized to C$35 Million In a significant move, Global Atomic Corporation is thrilled to announce the upsizing of its public offering to gross proceeds of C$35 million. This decision was spurred by high investor demand, reflecting the growing interest in the company's future prospects. Details of the Offering The previously...

Continue Reading
FLSmidth Launches Major Share Buy-Back Initiative

Updated Category News Views 145

FLSmidth Initiates Significant Share Buy-Back Program Recently, FLSmidth & Co. A/S took a major step toward enhancing shareholder value by starting a substantial share buy-back program valued at up to DKK 1.4 billion. This proactive approach is designed not just to support the stock price but also to demonstrate the company's commitment to its shareholders and the market....

Continue Reading
Innovative Partnership Enhances Community Oncology Practices

Updated Category News Views 196

Transforming Community Oncology Through Technology In the ever-evolving landscape of community oncology, innovation is key. AllyGPO, known for its commitment to independent oncology practices, has partnered with BioCareSD to revolutionize specialty drug management. This partnership is set to transform how oncology practices optimize their operations and deliver patient...

Continue Reading
Texas New Home Sales Decline Despite Increased Inventory Trends

Updated Category News Views 127

Overview of Texas New Home Sales Trends The Texas housing market is currently witnessing a noticeable decline in new home sales as of July. This pattern continues from previous months, aligning with forecasts made by industry experts who pointed to a peak in activity earlier this year. Ben Caballero, founder and CEO of HomesUSA.com, highlighted this trend by stating,...

Continue Reading